Cullinan Therapeutics (CGEM) Retained Earnings (2020 - 2026)
Cullinan Therapeutics' (CGEM) quarterly Retained Earnings came in at $127000.0 in Q1 2026, up 100.03% year-on-year from $63490.3 in Q1 2025, and up 100.02% quarter-over-quarter from -$588.1 million in Q4 2025.
Cullinan Therapeutics (CGEM) Retained Earnings (2020 - 2026) Analysis & Trends
Cullinan Therapeutics' Retained Earnings history runs 7 years deep, the most recent figure standing at $127000.0 for Q1 2026.
- On a quarterly basis, Retained Earnings rose 100.03% year-over-year to $127000.0 in Q1 2026; TTM through Mar 2026 was $127000.0, a 100.03% increase from a year earlier, with the FY2025 full-year figure at -$588.1 million, down 59.71% from the prior year.
- Retained Earnings climbed to $127000.0 in Q1 2026 per CGEM's latest filing, from -$588.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $3.9 million in Q2 2022 and bottomed at -$588.1 million in Q4 2025.
- The 5-year median for Retained Earnings is -$2.6 million (2022), against an average of -$121.6 million.
- Across the five-year window, Retained Earnings surged 3483.48% in 2022 and plunged 285357.36% in 2024, its largest moves.
- Year by year, Retained Earnings stood at -$2.6 million in 2022, then surged by 95.04% to -$129000.0 in 2023, then plunged by 285357.36% to -$368.2 million in 2024, then plunged by 59.71% to -$588.1 million in 2025, then surged by 100.02% to $127000.0 in 2026.
- Per Business Quant, the three latest CGEM Retained Earnings figures stand at $127000.0 (Q1 2026), -$588.1 million (Q4 2025), and $973000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Cullinan Therapeutics | 368.65 Mn | 368.65 Mn | - | 127,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127,000.00 |
| Dec 31, 2025 | -588.12 Mn |
| Sep 30, 2025 | 973,000.00 |
| Jun 30, 2025 | 607,000.00 |
| Mar 31, 2025 | -416.74 Mn |
| Dec 31, 2024 | -368.24 Mn |
| Sep 30, 2024 | 970,000.00 |
| Jun 30, 2024 | -476,000.00 |
| Mar 31, 2024 | -238.01 Mn |
| Dec 31, 2023 | -129,000.00 |
| Sep 30, 2023 | -177.05 Mn |
| Jun 30, 2023 | -1.63 Mn |
| Mar 31, 2023 | -105.66 Mn |
| Dec 31, 2022 | -2.60 Mn |
| Sep 30, 2022 | -3.93 Mn |
| Jun 30, 2022 | 3.89 Mn |
| Mar 31, 2022 | -171.00 Mn |
| Dec 31, 2021 | -838,000.00 |
| Sep 30, 2021 | -58,000.00 |
| Jun 30, 2021 | -115,000.00 |